PROGNOSTIC DETERMINANTS AND A NEW VIEW OF STAGING FOR PATIENTS WITH NASOPHARYNGEAL CARCINOMA

被引:60
作者
NEEL, HB
TAYLOR, WF
PEARSON, GR
机构
[1] MAYO CLIN & MAYO FDN, DEPT MED STAT & EPIDEMIOL, ROCHESTER, MN 55905 USA
[2] MAYO CLIN & MAYO FDN, DEPT IMMUNOL, ROCHESTER, MN 55905 USA
关键词
D O I
10.1177/000348948509400601
中图分类号
R76 [耳鼻咽喉科学];
学科分类号
100213 ;
摘要
引用
收藏
页码:529 / 537
页数:9
相关论文
共 23 条
[1]  
ABLASHI DV, 1983, CANCER RES, V43, P2375
[2]   THE PATHOLOGY OF HEAD AND NECK TUMORS - CARCINOMA OF THE NASOPHARYNX, .11. [J].
BATSAKIS, JG ;
SOLOMON, AR ;
RICE, DH .
HEAD & NECK SURGERY, 1981, 3 (06) :511-524
[3]  
COX DR, 1972, J R STAT SOC B, V34, P187
[4]   RECENT PROGRESS IN EPSTEIN-BARR VIRUS RESEARCH [J].
EPSTEIN, MA ;
ACHONG, BG .
ANNUAL REVIEW OF MICROBIOLOGY, 1977, 31 :421-445
[5]  
HARMER M, 1978, TNM CLASSIFICATION M
[6]   EPSTEIN-BARR VIRUS-SPECIFIC IGA SERUM ANTIBODIES AS AN OUTSTANDING FEATURE OF NASOPHARYNGEAL CARCINOMA [J].
HENLE, G ;
HENLE, W .
INTERNATIONAL JOURNAL OF CANCER, 1976, 17 (01) :1-7
[7]   NASOPHARYNGEAL CARCINOMA - SIGNIFICANCE OF CHANGES IN EPSTEIN-BARR VIRUS-RELATED ANTIBODY PATTERNS FOLLOWING THERAPY [J].
HENLE, W ;
HO, JHC ;
HENLE, G ;
CHAU, JCW ;
KWAN, HC .
INTERNATIONAL JOURNAL OF CANCER, 1977, 20 (05) :663-672
[8]  
Ho J H, 1978, IARC Sci Publ, P99
[9]  
HOPPE RT, 1976, CANCER, V37, P2605, DOI 10.1002/1097-0142(197606)37:6<2605::AID-CNCR2820370607>3.0.CO
[10]  
2-W